ADA 2026 GLP-1 Pipeline: Retatrutide, CagriSema, Orforglipron The next wave of incretin therapies unveiled in New Orleans. d [Internet]. 2026 Jul. 7 [cited 2026 Jul. 28];4(23):46-7. Available from: https://thediabzen.com/index.php/d/article/view/66